1. Home
  2. DOMO vs ATYR Comparison

DOMO vs ATYR Comparison

Compare DOMO & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Domo Inc. Class B

DOMO

Domo Inc. Class B

HOLD

Current Price

$8.64

Market Cap

477.0M

Sector

Technology

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.74

Market Cap

79.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOMO
ATYR
Founded
2010
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
477.0M
79.2M
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
DOMO
ATYR
Price
$8.64
$0.74
Analyst Decision
Buy
Buy
Analyst Count
8
6
Target Price
$14.38
$8.75
AVG Volume (30 Days)
1.0M
2.2M
Earning Date
12-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$318,002,000.00
$190,000.00
Revenue This Year
$2.32
N/A
Revenue Next Year
$2.72
$18,728.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.01
$0.64
52 Week High
$18.49
$7.29

Technical Indicators

Market Signals
Indicator
DOMO
ATYR
Relative Strength Index (RSI) 28.08 41.71
Support Level $8.43 $0.70
Resistance Level $8.97 $0.83
Average True Range (ATR) 0.55 0.05
MACD -0.02 0.01
Stochastic Oscillator 6.90 26.75

Price Performance

Historical Comparison
DOMO
ATYR

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: